Patents by Inventor Mark Parry-Billings

Mark Parry-Billings has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Drug delivery device for the treatment of patients with respiratory diseases
    Patent number: 11052202
    Abstract: Drug delivery devices that include a microphone and processing circuitry that can detect operating events, such as peak inspiratory flow (PIF) and Breath Actuated Mechanism (BAM) in dry powder inhalers can be used to improve clinical trials by providing information about the way in which the inhalers under test are being used.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: July 6, 2021
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Mark Parry-Billings, Mario Scuri, Maria Chiara Taverna
  • DRUG DELIVERY DEVICE FOR THE TREATMENT OF PATIENTS WITH RESPIRATORY DISEASES
    Publication number: 20140158126
    Abstract: Drug delivery devices that include a microphone and processing circuitry that can detect operating events, such as peak inspiratory flow (PIF) and Breath Actuated Mechanism (BAM) in dry powder inhalers can be used to improve clinical trials by providing information about the way in which the inhalers under test are being used.
    Type: Application
    Filed: November 1, 2013
    Publication date: June 12, 2014
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Mark PARRY-BILLINGS, Mario Scuri, Maria Chiara Taverna
  • No-donating corticosteroid with improved pharmacokinetic, anti-inflammatory and vasodilatory properties
    Publication number: 20090088411
    Abstract: There are herein provided methods of treatment and nitric oxide donating compositions of matter for the treatment of respiratory diseases and associated conditions.
    Type: Application
    Filed: August 8, 2008
    Publication date: April 2, 2009
    Applicant: Topigen Pharmaceuticals Inc.
    Inventors: Paolo Renzi, Rene Pageau, Mark Parry-Billings